新娛科控股(06933.HK)上半年淨虧損1420.1萬元 同比減少26.7%
格隆匯8月29日丨新娛科控股(06933.HK)公佈中期業績,截至2023年6月30日止六個月,集團於期內並未獲得新的遊戲版號,目前集團仍有兩款遊戲待國家新聞出版總署審批。於期內集團的收益減少至約人民幣86.8萬元,較去年同期減少94.5%。然而,通過有效控制成本,集團錄得期內淨虧損人民幣1420.1萬元,較去年同期減少26.7%。
就區塊鏈技術業務方面,若干與加密貨幣有關的違約事件發生對區塊鏈技術業務產生不利影響,出於審慎考慮,集團在期內減少持有加密貨幣並暫停為領先的區塊鏈協議上運營的流動性池提供數字化服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.